Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility
AuthorTan, SM; Ziemann, M; Thallas-Bonke, V; Snelson, M; Kumar, V; Laskowski, A; Nguyen, T-V; Huynh, K; Clarke, MV; Libianto, R; ...
PublisherAMER DIABETES ASSOC
University of Melbourne Author/sLibianto, Renata; MacIsaac, Richard; Power, David; Clarke, Michele; El-Osta, Assam; Meikle, Peter; Ekinci, Elif; Huynh, Kevin; Nguyen, Tuong-Vi
AffiliationMicrobiology and Immunology
Obstetrics and Gynaecology
Medicine (Austin & Northern Health)
Medicine (St Vincent's)
Melbourne Medical School
Document TypeJournal Article
CitationsTan, S. M., Ziemann, M., Thallas-Bonke, V., Snelson, M., Kumar, V., Laskowski, A., Nguyen, T. -V., Huynh, K., Clarke, M. V., Libianto, R., Baker, S. T., Skene, A., Power, D. A., MacIsaac, R. J., Henstridge, D. C., Wetsel, R. A., El-Osta, A., Meikle, P. J., Wilson, S. G. ,... Coughlan, M. T. (2020). Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility. DIABETES, 69 (1), pp.83-98. https://doi.org/10.2337/db19-0043.
Access StatusAccess this item via the Open Access location
Open Access URLAccepted version
The sequelae of diabetes include microvascular complications such as diabetic kidney disease (DKD), which involves glucose-mediated renal injury associated with a disruption in mitochondrial metabolic agility, inflammation, and fibrosis. We explored the role of the innate immune complement component C5a, a potent mediator of inflammation, in the pathogenesis of DKD in clinical and experimental diabetes. Marked systemic elevation in C5a activity was demonstrated in patients with diabetes; conventional renoprotective agents did not therapeutically target this elevation. C5a and its receptor (C5aR1) were upregulated early in the disease process and prior to manifest kidney injury in several diverse rodent models of diabetes. Genetic deletion of C5aR1 in mice conferred protection against diabetes-induced renal injury. Transcriptomic profiling of kidney revealed diabetes-induced downregulation of pathways involved in mitochondrial fatty acid metabolism. Interrogation of the lipidomics signature revealed abnormal cardiolipin remodeling in diabetic kidneys, a cardinal sign of disrupted mitochondrial architecture and bioenergetics. In vivo delivery of an orally active inhibitor of C5aR1 (PMX53) reversed the phenotypic changes and normalized the renal mitochondrial fatty acid profile, cardiolipin remodeling, and citric acid cycle intermediates. In vitro exposure of human renal proximal tubular epithelial cells to C5a led to altered mitochondrial respiratory function and reactive oxygen species generation. These experiments provide evidence for a pivotal role of the C5a/C5aR1 axis in propagating renal injury in the development of DKD by disrupting mitochondrial agility, thereby establishing a new immunometabolic signaling pathway in DKD.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References
- Medicine (Austin & Northern Health) - Research Publications 
- Medicine (St Vincent's) - Research Publications 
- Melbourne Medical School Collected Works - Research Publications 
- Microbiology & Immunology - Research Publications 
- Obstetrics and Gynaecology - Research Publications 
- Clinical Pathology - Research Publications 
- Minerva Elements Records